Wilfactin

Wilfactin is a human von Willebrand factor concentrate used to manage bleeding disorders related to von Willebrand disease. This factor helps control and prevent bleeding episodes when administered intravenously. Suitable for patients requiring replacement therapy.

Wilfactin is primarily used to treat and prevent bleeding in individuals with von Willebrand disease, a condition that affects blood clotting. It works by replacing the missing or defective von Willebrand factor in the blood, which is essential for proper clotting. This medication is often used before surgeries or dental procedures to reduce bleeding risk. It may also be used in emergencies to stop severe bleeding episodes.

When administered, Wilfactin helps restore normal clotting function by providing the necessary von Willebrand factor. Patients may experience improved bleeding control and reduced frequency of bleeding episodes. Some individuals report a general sense of improved well-being due to fewer bleeding-related complications. The effects are typically observed shortly after infusion.

Wilfactin should be handled and administered by healthcare professionals in a clinical setting. Patients with known allergies to human blood products or any components of Wilfactin should avoid its use. Regular monitoring for signs of allergic reactions or infusion-related issues is recommended. Keep the product stored at the recommended temperature to maintain its effectiveness.

Wilfactin may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Patients should inform their healthcare provider about all medications they are taking. No significant interactions with common substances like alcohol or caffeine have been widely reported, but caution is advised. Always consult a healthcare professional before combining treatments.